Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 28 of KYNTRA BIO, INC.'s SEC filings and found 2 ATM programs and 1 shelf registration on file for KYNB. The latest dilution event on file is ATM sales on Aug 13, 2026. Analysis updated Oct 7, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
HEPAHepion Pharmaceuticals, Inc.
QNTMQuantum BioPharma Ltd.
ESLAEstrella Immunopharma, Inc.
PLURPluri Inc. Common Stock
MCRBSeres Therapeutics, Inc.
CNTXContext Therapeutics Inc.
JSPRJasper Therapeutics, Inc.
AKTXAkari Therapeutics, Plc
AEONAEON Biopharma, Inc.
ABOSAcumen Pharmaceuticals, Inc.
BOLTBolt Biotherapeutics, Inc.
ACTUActuate Therapeutics Inc
ALLRAllarity Therapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
MRKRMarker Therapeutics, Inc.